We offer interpreting service and counselling on the diagnosis of patients with hemoglobinopathies and carriers of hemoglobinopathies (thalassemias, sickle cell disease and other hemoglobin variants). We manage the screening program for hemoglobinopathies in pregnant women in the Central Region Denmark and collaborate with the Department of Clinical Genetics and the Department of Obstetrics and Gynecology.

Hemoglobin type is determined by HPLC and genetic analyses (gene sequencing and gap PCR). All methods are accredited by the ISO15189 standard.

Further information:
Please contact consultant, MD, PhD Mie Samson:
miesamso@rm.dk Tel: +45 4014 4864.

Revised: 5 April 2017